In Vitro Diagnostics Market Research Reports & Industry Analysis

The publications below represent comprehensive market research on components of the global market for in vitro diagnostics. Reports, published by several different research companies, address financial analyses of major companies, overview analyses of the global market, and specific analyses on individual countries or individual and more specific segments of the market, such as cell analysis.
...Show More ...Show Less


In Vitro Diagnostics Industry Research & Market Reports

  • Oxidative Stress Assays

    ... at a CAGR of 8.4% over the analysis period 2024-2030. Oxidative Stress Assays Consumables, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.3 Billion by the ... Read More

  • Malaria Diagnostics

    ... CAGR of 5.6% over the analysis period 2024-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$685.9 Million by the end of the ... Read More

  • Mycoplasma Testing

    ... CAGR of 8.6% over the analysis period 2024-2030. Mycoplasma Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$940.8 Million by the ... Read More

  • Ovulation Test

    ... CAGR of 4.0% over the analysis period 2024-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More

  • Veterinary Hematology Analyzers

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More

  • Hematology Testing Products

    ... at a CAGR of 4.4% over the analysis period 2024-2030. Hematology Testing Instruments & Software, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$9.8 Billion by ... Read More

  • Hemostasis Products

    ... CAGR of 3.7% over the analysis period 2024-2030. Infusible Hemostasis Products, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end of the ... Read More

  • Home Pregnancy Tests (HPT)

    ... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Digital Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$597.6 Million by the ... Read More

  • Arbovirus Testing

    ... CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis ... Read More

  • Biochemistry Analyzers

    ... CAGR of 5.4% over the analysis period 2024-2030. Clinical Diagnostics Application, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.4 Billion by the end of the ... Read More

  • Blood Culture Tests

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More

  • Carrier Screening

    ... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More

  • Cell Counting

    ... CAGR of 5.3% over the analysis period 2024-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end of the ... Read More

  • Cell Sorting

    ... CAGR of 9.2% over the analysis period 2024-2030. Cell Sorters, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$862.0 Million by the end of the analysis ... Read More

  • Laboratory Benchtop Automation

    ... at a CAGR of 4.8% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.7 Billion by ... Read More

  • Microfluidics

    ... 16.0% over the analysis period 2024-2030. Microfluidics Devices, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$63.5 Billion by the end of the analysis period. Growth ... Read More

  • In Vitro Diagnostics

    ... at a CAGR of 3.4% over the analysis period 2024-2030. IVD Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the ... Read More

  • Pneumonia Therapeutics

    ... CAGR of 6.7% over the analysis period 2024-2030. Pneumonia Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis ... Read More

  • Western Blotting

    ... CAGR of 5.3% over the analysis period 2024-2030. Western Blotting Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.1 Billion by the end of the ... Read More

  • Microbiology Culture

    ... CAGR of 3.8% over the analysis period 2024-2030. Eukaryotic Culture, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.2 Billion by the end of the analysis ... Read More

  • STD Testing

    ... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More

  • Medical Device Market Medical Device Market by Device Type, Function, Durability, Therapeutic Segment, Risk Classification, Manufacture Method, Delivery/Acquisition, Operational Support Model, Connectivity and Region 2025 – 2030

    ... (hospital, home, clinic, etc.), function (critical care, diagnostic, dental, etc.), durability, risk classification, manufacturing method (traditional vs. 3D printed), delivery/acquisition method, operational support model, and connectivity (Bluetooth, cellular, Wi-Fi, etc.). It also examines the therapeutic ... Read More

  • Chlamydia Infection Diagnostics and Therapeutics

    ... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Chlamydia Infection Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 ... Read More

  • Thyroid Function Tests

    ... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More

  • Forensic Technologies and Services

    ... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More

Cookie Settings